Stockreport

CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) [Seeking Alpha]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF CX-2051 shows a promising 28% response rate in late-line mCRC, but severe diarrhea remains a significant safety concern. Clarity on registrational strategy and durabi [Read more]